CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Goodwill & Intangibles (2021 - 2026)

Updated

CytoMed Therapeutics' Goodwill & Intangibles was $104,396 in Q2 2026, up 43.9% from $72,556 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

At the end of FY2025, Goodwill & Intangibles at CytoMed Therapeutics came in at $95,594, up 37.2% from FY2024.

  • Goodwill & Intangibles shows a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
  • In earlier years, Goodwill & Intangibles was $69,658 in FY2024 (+653.4%), $9,245 in FY2023 (-32.3%), $13,648 in FY2022 (-42.7%) and $23,839 in FY2021 (-47.1%).
  • The Q2 2026 figure marks the highest quarterly Goodwill & Intangibles in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CytoMed Therapeutics 10.88 Mn -200,496.58 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104,396.00
Dec 31, 2025 96,365.46
Jun 30, 2025 72,556.00
Dec 31, 2024 69,952.80
Jun 30, 2024 11,012.00
Dec 31, 2023 9,194.22
Jun 30, 2023 13,815.00
Dec 31, 2022 13,553.05
Dec 31, 2021 23,597.40
API Access

CytoMed Therapeutics Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=GDTC&period=max&api_key=YOUR_API_KEY